Join the Methadose group to help and get support from people like you.
Methadose News
Inmates in Many U.S. Jails Have No Access to Meds That Fight Opioid Addiction
TUESDAY, Sept. 24, 2024 – Opioid use disorder can be a contributing factor to Americans landing in the nation's prisons and jails, but those inmates typically have no access to medications that...
Acupuncture Can Reduce Methadone Dose, Opioid Craving
MONDAY, July 8, 2024 – For individuals with opioid use disorder receiving methadone maintenance treatment (MMT), eight weeks of acupuncture is superior to sham acupuncture for reducing methadone...
Only 1 in 4 People Who Need Meds to Fight Opioid Addiction Get Them
THURSDAY, June 27, 2024 – Just 25% of people battling opioid use disorder are getting medications aimed at helping them quit and potentially avoid an overdose, new data shows. Boosting access to...
Most Outpatient Mental Health Clinics Don't Offer Opioid Addiction Meds
WEDNESDAY, June 19, 2024 – Only a third of outpatient mental health facilities offer medications essential for treating opioid addiction, a new study finds. Standard care for treating people with...
Congenital Malformation Risk Lower With Buprenorphine Versus Methadone
THURSDAY, Jan. 25, 2024 – The risk for congenital malformations is lower in association with buprenorphine versus methadone for opioid use disorder in pregnancy, according to a study published...
Mindfulness-Oriented Recovery Enhancement Boosts Methadone Treatment
MONDAY, Jan. 8, 2024 – Telehealth-delivered mindfulness-oriented recovery enhancement (MORE) is a feasible and effective adjunct to methadone treatment (MT) for individuals with opioid use disorder...
FDA Medwatch Alert: Opioid Addiction Medications in Patients Taking Benzodiazepines or CNS Depressants: Drug Safety Communication - Careful Medication Management Can Reduce Risks
ISSUE: Based on additional review, FDA is advising that the opioid addiction medications buprenorphine and methadone should not be withheld from patients taking benzodiazepines or other drugs that...
FDA Medwatch Alert: Opioid Pain or Cough Medicines Combined With Benzodiazepines: Drug Safety Communication - FDA Requiring New Boxed Warnings About Serious Risks and Death
ISSUE: FDA review has found that the growing combined use of opioid medicines with benzodiazepines or other drugs that depress the central nervous system (CNS) has resulted in serious side effects,...
FDA Medwatch Alert: Opioid Pain Medicines: Drug Safety Communication - New Safety Warnings Added to Prescription Opioid Medications
ISSUE: FDA is warning about several safety issues with the entire class of opioid pain medicines. See the FDA Drug Safety Communication for a complete listing. These safety risks are potentially h...
FDA Medwatch Alert: Compounded Drugs Stored in Becton-Dickinson (BD) 3 ml and 5 ml Syringes: FDA Warning - Do Not Use
ISSUE: FDA is alerting health care professionals not to administer to patients compounded or repackaged drugs that have been stored in 3 milliliter (ml) and 5ml syringes manufactured by...
Further information
Related condition support groups
Opiate Withdrawal, Chronic Pain, Pain